Betahistine: Clinical Trials

5 trials of Betahistine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 4, Unknown 1
Phase 21Unknown 1

Follow Betahistine: new trials by email Literature Review of Betahistine trials Research Report on Betahistine

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation
YPS-201b, betahistine - Meniere's Disease
Phase 1 / Phase 2UnknownSeoul National University Hospital1202023-09-182024-12-05
Pharmacokinetic Profile of Betahistine With and Without Selegiline in Healthy Volunteers
Betahistine dihydrochloride, Selegiline-hydrochloride - Ménière's Disease
Phase 1CompletedLudwig-Maximilians - University of Munich152021-06-022023-07-12
Evaluation of Safety, Drug-Drug Interactions and Pharmacokinetic Profiles of Co-Administration of Betahistine With Olanzapine in Healthy Female Subjects
Betahistine - Healthy
Phase 1CompletedOBEcure Ltd.502009-02-012009-05-05
Effects of Using Betahistine to Treat Adults With Attention Deficit Hyperactivity Disorder
Betahistine Hydrochloride, Placebo Capsule - Attention Deficit Disorder With Hyperactivity
Phase 1CompletedP2D, Inc.162009-01-012013-09-26
Effects of Betahistine Hydrochloride in Overweight Women
Betahistine Hydrochloride - Obesity, Overweight
Phase 1CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1502007-04-102019-12-16

Conditions studied

Meniere Disease (2)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  Obesity (1)  ·  Overnutrition (1)  ·  Overweight (1)  ·  Weight Gain (1)

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Ludwig-Maximilians - University of Munich (1)  ·  OBEcure Ltd. (1)  ·  P2D, Inc. (1)  ·  Seoul National University Hospital (1)

Countries

United States (2)  ·  Germany (1)  ·  Romania (1)  ·  South Korea (1)

Top investigators

Charles H. Pierce, MD, PhD (1)  ·  Jack A Yanovski, M.D. (1)  ·  Michael Strupp, M.D. (1)

Results publications

PMID 20881066, PMID 34519823, PMID 37920833, PMID 41905546

NIH funding

R43MH082461 (1)